Madoff R D, Baeten C G, Christiansen J, Rosen H R, Williams N S, Heine J A, Lehur P A, Lowry A C, Lubowski D Z, Matzel K E, Nicholls R J, Seccia M, Thorson A G, Wexner S D, Wong W D
Division of Colon and Rectal Surgery, University of Minnnesota Medical School, Minneapolis, USA.
Dis Colon Rectum. 2000 Feb;43(2):135-41. doi: 10.1007/BF02236969.
Anal sphincter replacement offers a new treatment option for patients with severe refractory fecal incontinence or for those who require abdominoperineal resection for localized malignancy. The purpose of this study was to review the current status of anal sphincter replacement, formulate a consensus statement regarding its current use, and outline suggestions for future development.
Four areas of interests were selected: indications for sphincter replacement, continence scoring and quality of life, choice of therapy, and dissemination of new technology. A questionnaire regarding these issues was developed and circulated to working party members; its results served as the basis for this consensus document.
Both electrically stimulated skeletal muscle neosphincter and artificial anal sphincter are options for patients with end-stage fecal incontinence. Electrically stimulated skeletal muscle neosphincter is also appropriate for reconstruction after surgical excision of the anorectum in selected cases. Avoidance of complications requires strict attention to sterile technique, prophylactic antibiotics, and deep venous thrombus prophylaxis. A standardized scoring system is proposed that evaluates both continence and evacuation. Quality of life is a critical endpoint for assessing sphincter replacement, and use of The American Society of Colon and Rectal Surgeons incontinence-specific quality-of-life instrument is recommended. As the efficacy of sphincter replacement becomes proven, dissemination of the technique should occur in a controlled manner to ensure adequate surgeon training, minimization of complications, and optimization of results.
Sphincter replacement by electrically stimulated skeletal muscle neosphincter and artificial anal sphincter provide a continent option for patients with end-stage fecal incontinence and those requiring abdominoperineal resection. The guidelines offered in this document are intended to facilitate the controlled and safe development and acceptance of these new techniques.
肛门括约肌置换为重度难治性大便失禁患者或因局部恶性肿瘤需行腹会阴联合切除术的患者提供了一种新的治疗选择。本研究的目的是回顾肛门括约肌置换的现状,就其当前应用形成共识声明,并概述未来发展的建议。
选择四个感兴趣的领域:括约肌置换的适应证、控便评分与生活质量、治疗选择以及新技术的传播。针对这些问题编制了一份问卷并分发给工作组成员;问卷结果作为本共识文件的基础。
电刺激骨骼肌新括约肌和人工肛门括约肌都是终末期大便失禁患者的选择。在某些特定病例中,电刺激骨骼肌新括约肌也适用于直肠肛管手术切除后的重建。避免并发症需要严格注意无菌技术、预防性使用抗生素以及预防深静脉血栓形成。提出了一种标准化评分系统,用于评估控便和排便情况。生活质量是评估括约肌置换的关键终点,建议使用美国结直肠外科医师协会的大便失禁特异性生活质量量表。随着括约肌置换的疗效得到证实,该技术的传播应以可控方式进行,以确保外科医生得到充分培训、将并发症降至最低并优化治疗效果。
电刺激骨骼肌新括约肌和人工肛门括约肌置换为终末期大便失禁患者以及需要行腹会阴联合切除术的患者提供了一种控便选择。本文提供的指南旨在促进这些新技术的可控且安全的发展与应用。